We next considered if istradefylline (KW6002), a clinically available A2AR antagonist approved for treating Parkinson’s disease with less selectivity and affinity to A2AR than SCH5826122 could recapitulate this crosstalk between trigeminal nerve endings and OSCC. The gene discussed is ADORA2A; the disease is Parkinson disease.